Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed at $1.23 in the last session, down -3.91% from day before closing price of $1.28. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 0.51 million shares were traded. CTXR stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.225.
Ratios:
We take a closer look at CTXR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.14 and its Current Ratio is at 0.47. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On November 30, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTXR now has a Market Capitalization of 20924996 and an Enterprise Value of 19219900.
Stock Price History:
The Beta on a monthly basis for CTXR is 1.41, which has changed by -0.86179775 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, CTXR has reached a high of $12.84, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -2.38%, while the 200-Day Moving Average is calculated to be -23.40%.
Shares Statistics:
According to the various share statistics, CTXR traded on average about 478.42K shares per day over the past 3-months and 610610 shares per day over the past 10 days. A total of 17.01M shares are outstanding, with a floating share count of 16.04M. Insiders hold about 5.74% of the company’s shares, while institutions hold 5.46% stake in the company. Shares short for CTXR as of 1759190400 were 978825 with a Short Ratio of 2.05, compared to 1756425600 on 795318. Therefore, it implies a Short% of Shares Outstanding of 978825 and a Short% of Float of 5.9299998.
Earnings Estimates
The performance of Citius Pharmaceuticals Inc (CTXR) in the stock market is under the watchful eye of 1.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.3 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$2.08 and -$2.08 for the fiscal current year, implying an average EPS of -$2.08. EPS for the following year is $1.9, with 1.0 analysts recommending between $1.9 and $1.9.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $3.46M. There is a high estimate of $3.46M for the next quarter, whereas the lowest estimate is $3.46M.
Based on 2 analysts’ estimates, the company’s revenue will be $63.82M in the next fiscal year. The high estimate is $78.29M and the low estimate is $49.35M.
